Drug
Fosfomycin sodium clinical trials
Also written Fosfomycin disodium and ZTI-01.
A product of Fosfomycin; its studies count on that page too.
- studies test it
- 9
- open now
- 2
- in phase 3
- 2
- first study started
- 2014
Keep track of what changes. Save the fosfomycin sodium studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2014 (2)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 5
Nabriva Therapeutics AG (3) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Zealand University Hospital (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1) · Meitheal Pharmaceuticals, Inc. (1)
Often tested with
Tested in the same studies.
Therapeutic Endoscopic Procedure (1) · Metronidazole (1)
Studies
Open first, then newest update. How each study uses fosfomycin sodium is read from its arms, and is right about nine times in ten.
Testing it · 9
- Evaluation of the Excretion of Fosfomycin Into Breast Milk Following a Single Intravenous Dose of ZTI-01 (6 g) in Healthy Lactating WomenRecruitingPhase 4Meitheal Pharmaceuticals, Inc.NCT07618299Written as ZTI-01
- PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)RecruitingPhase 1Nabriva Therapeutics AGNCT03709914Written as ZTI-01 100 mg/kg
- Intravenous Fosfomycin Pharmacokinetics StudyCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT03910673Written as Fosfomycin disodium
- Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (MEFO-trial)CompletedPhase 2Zealand University HospitalNCT04312360Written as therapeutic endoscopy with metronidazole and fosfomycin disodium
- Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.ColiCompletedPhase 3Fundación Pública Andaluza para la gestión de la Investigación en SevillaNCT02142751Written as Fosfomycin sodium intravenous
- Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP InfectionsCompletedPhase 2/3Nabriva Therapeutics AGNCT02753946Written as ZTI-01
- 4-way Crossover QT Evaluation in Healthy SubjectsCompletedPhase 1Nabriva Therapeutics AGNCT03709927Written as ZTI-01
- Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant RecipientsCompletedPhase 4Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranNCT03235947Written as Fosfomycin disodium
- Safety, Tolerability and PK 3-Period Crossover Study Comparing 2 Single Doses of ZTI-01 and Monurol® in Healthy SubjectsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02178254Written as Fosfomycin disodium
Codes
What other systems call fosfomycin sodium · ClinicalTrials.gg INT002203
- MeSH (NLM) C000732034fosfomycin sodiumOne source NLM
- UNII (FDA) 97MMO19FNOFOSFOMYCIN SODIUMConfirmed FDA, NLM, Wikidata
- Wikidata Q27272022fosfomycin sodiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C217926Fosfomycin SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000732034 | fosfomycin sodium | One source NLM |
| UNII (FDA) | 97MMO19FNO | FOSFOMYCIN SODIUM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27272022 | fosfomycin sodium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C217926 | Fosfomycin Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.